Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 269.23 M290.82 M287.29 M400.25 M236.7 M 1.22 B Research & development 110.51 M111.86 M113.38 M124.14 M99.05 M 448.43 M Operating income -22.33 M76.43 M82.71 M110.94 M119.85 M 389.93 M Non-Operating Income, Total -10.99 M-25.28 M9.37 M7.36 M9.41 M 861 K Interest expense, net of interest capitalized 3.4 M3.77 M5.68 M5.65 M— — Non-Operating Income, excl. Interest Expenses -10.99 M-25.28 M9.37 M7.36 M0 -8.55 M Unusual income/expense ————9.41 M — Pretax income -33.32 M51.15 M92.08 M118.02 M129.26 M 390.51 M Equity in earnings ————— — Taxes 18.78 M22.31 M16.58 M24.3 M24.6 M 87.78 M Non-controlling/minority interest ————— — After tax other income/expense -15.37 M-19.54 M-1.89 M1.56 M2.26 M -17.61 M Net income before discontinued operations -52.1 M28.84 M75.5 M110.73 M104.66 M 319.74 M Discontinued operations ————-34.98 M — Net income -52.1 M28.84 M75.5 M110.73 M69.68 M 284.76 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -52.1 M30.71 M78.84 M115.65 M73.01 M 298.22 M Basic earnings per share (Basic EPS) -0.490.280.761.040.72 2.8 Diluted earnings per share (Diluted EPS) -0.490.250.6310.6 2.48 Average basic shares outstanding 107.08 M103.21 M99.33 M102.36 M96.23 M — Diluted shares outstanding 107.08 M121.51 M124.96 M124.11 M121.03 M — EBITDA 4.96 M111.93 M106.97 M154.29 M135.16 M 508.35 M EBIT -22.33 M76.43 M82.71 M129.4 M119.85 M 408.38 M Cost of revenue 192.06 M193.55 M194.65 M261.81 M175.68 M 825.68 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 27.29 M35.5 M24.26 M24.89 M15.31 M 99.97 M